Kinase inhibitor Gefitinib – Arrhythmogenic effects on cardiomyocytes
FLEXcyte 96 data and applications:
Cells were kindly provided by FUJIFILM Cellular Dynamics.
Exemplary arrhythmia as observed 24 h after application of Kinase inhibitor Gefitinib. Aftercontractions (regular intervals and irregular intervals) and Fibrillations were observed, respectively.